Nissin Foods Announces 2022 Interim Results ACN Newswire

Nissin Foods Announces 2022 Interim Results

August 30, 2022
HONG KONG, Aug 30, 2022 - (ACN Newswire via SEAPRWire.com) - Nissin Foods Company Limited ("Nissin Foods" or the "Company", together with its subsidiaries, the "Group"; Stock code: 1475) has today announced its interim results for the six months ended 30 June 2022 ("the reporting period"). Highlights-- Revenue from the Hong Kong operations increased solidly by 11.4% year-on-year to HK$759.9 million, mainly attributable to the strong demand for instant noodles and frozen food products driven by the hoarding behaviour of consumers. Revenue from Mainland China operations increased by 8.7% to HK$1,273.2 million, thanks to the growth in sales volume of cup-type instant noodles. -- In the face of rising production costs and raw material prices, Nissin Foods will implement the second phase of its price adjustment strategy in Hong Kong, for the products that were not included in the first phase implemented in April 2022. Their ex-factory price will be adjusted upward by a high single-digit percentage on average, starting from September 2022. -- "Nissin Foodium", Nissin's inaugural membership programme for Hong Kong and Mainland China has been launched respectively in July and August 2022. The "Nissin Foodium" in the WeChat Mini Program offers the members a series of exclusive benefits, exciting rewards and interactive games. The Group's revenue increased by 9.7% year-on-year ("YoY") to HK2,033.1 million (2021: HK$1,853.8 million). The Group's EBITDA grew by 8.4% YoY to HK$305.1 million (2021: HK$281.3 million), representing an EBITDA margin of 15.0% (2021: 15.2%). Profit attributable to owners of the Company amounted to HK$164.9 million (2021: HK$170.9 million). The Group's basic earnings per share was 15.80 HK cents (2021: 15.94 HK cents). Hong Kong OperationsRevenue from the Hong Kong operations increased solidly by 11.4% YoY to HK$759.9 million (2021: HK$682.2 million), mainly attributable to the strong demand for instant noodles and frozen food products driven by the hoarding behaviour of consumers. Segment results amounted to HK$50.0 million (2021:HK$52.6 million), owing to the higher-than-usual production and logistics costs that occurred during the fifth wave of the pandemic. Revenue from the Hong Kong operations accounted for 37.4% (2021: 36.8%) of the Group's revenue. The improvement in the performance of both cup-type and bag-type instant noodles was obvious, as consumers were more inclined to stay at home. To further complement its instant noodles portfolio, the Group launched various new flavours under the "Roah", Nissin "U.F.O." and "Fuku" brands. Frozen food products also demonstrated a strong demand due to the resurgence of the pandemic in Hong Kong. For the "KAGOME" business, plant-based soy and oat milks were launched to promote nutritious and healthy choices to health-conscious consumers. The Group replicated the success of granola in Greater China in new markets in Southeast Asia. The sales volume grew considerably in Singapore and Thailand during the first half of the year. The fresh-cut vegetable business has seen growing demand, and the distribution channels have further expanded from supermarkets to restaurants. Mainland China OperationsRevenue from the Mainland China operations increased by 8.7% (in local currency: 8.4%) to HK$1,273.2 million (2021: HK$1,171.6 million) thanks to the growth in sales volume of cup-type instant noodles as consumers continued to favour higher-quality products, offset by a drop in the distribution business. Segment results increased favourably by 14.1% to HK$165.9 million (2021: HK$145.4 million), mainly attributable to the sound performance of organic revenue growth, coupled with the price adjustment implemented during the period. Revenue from the Mainland China operations accounted for 62.6% (2021: 63.2%) of the Group's revenue. As with "Cup Noodles" in Hong Kong, the Company has been upgrading the product in Mainland China to feature smoother noodle texture and a thicker soup base since May 2021. A positive response was received from customers, with the sales volume continuously expanding during the period under review. Also, the Company continued its geographical business expansion strategy in Mainland China and explored certain new markets in the Western and Northern regions of China. Leveraging its diversified product portfolio, it seized the opportunity to promote other product categories such as frozen pasta and ramen during the lockdown in Shanghai due to resurgence of COVID-19, and the sales volume of these products was considerably broadened as a result. ProspectsThe Group is cautiously optimistic about the long-term business development in the regions in which it operates and will continue to explore ways to better alleviate the cost pressure amid this competitive landscape. While the high prices of key raw materials such as wheat flour and palm oil are starting to decline, there remains a veil of uncertainty over the future outlook of the business environment considering the rising risk of worldwide stagflation. In Hong Kong, the cost pressure has not yet been fully released. In the face of rising production costs and raw material prices, the Group will implement the second phase of its price adjustment strategy for the products that were not included in the first phase implemented in April 2022, with an average increase of a high single-digit percentage to the ex-factory price, starting from September 2022.Furthermore, a new membership programme designed to strengthen the connection with consumers and bring them enjoyment has been launched in both Hong Kong and Mainland China in July and August 2022, respectively. The "Nissin Foodium" in the WeChat Mini Program offers members a series of exclusive benefits, exciting rewards and interactive games. To enjoy additional benefits and surprises, consumers are encouraged to scan the unique QR code on the products by using the mini program and complete various tasks to earn points. It aims to enhance the Group's customer retention rate, boost product sales and better understand consumer preferences. Building on a solid foundation, well-diversified product portfolio and the premiumisation strategy pursued, the Company is well-positioned to deliver continuous revenue and earnings growth, as well as expand business territories with increasing brand recognition in Hong Kong and Mainland China for the years ahead. Mr Kiyotaka ANDO, Executive Director, Chairman and Chief Executive Officer of Nissin Foods, said, "Despite the challenging conditions arising from increasing raw material prices, the Group has achieved solid revenue growth in both Hong Kong and Mainland China for the first half of this year. Thanks to the continuous support from customers in both Hong Kong and Mainland China, our products are able to sustain the growth momentum. We are dedicated to pursuing a premiumisation strategy and providing good quality food to bring contentment and an enjoyable experience to our valuable consumers. 'Nissin Foodium' is our first membership programme and part of our efforts to enhance consumer experience and strengthen our connection with them. Leveraging our research and production capabilities, as well as our management and marketing expertise, we will continue to invest in our products, people and production, so as to strengthen our overall competitiveness and ensure sustainable growth." About Nissin Foods Company LimitedNissin Foods Company Limited (The "Group"; Stock code: 1475) is a renowned food company in Hong Kong and Mainland China with a diversified portfolio of well-known and highly popular brands and the largest instant noodle company in Hong Kong. The Group officially established its presence in Hong Kong in 1984. The Group primarily manufactures and sells instant noodles, frozen foods and other food products under its two core corporate brands, namely "NISSIN" and "DOLL" together with a diversified portfolio of iconic household premium food brands. The Group's five flagship product brands, namely "Cup Noodles", "Demae Iccho", "Doll Instant Noodle", "Doll Dim Sum" and "Fuku" are also among the most popular choices in their respective food product categories in Hong Kong. In the Mainland China market, the Group has introduced technology innovation through the "ECO Cup" concept and primarily focuses its sales efforts in first-and second-tier cities. Nissin Foods is a constituent of eight Hang Seng Indexes, namely: Hang Seng Composite Index, Hang Seng Consumer Goods & Services Index, Hang Seng Stock Connect Hong Kong Index, Hang Seng Stock Connect Hong Kong MidCap & SmallCap Index, Hang Seng Stock Connect Hong Kong SmallCap Index, Hang Seng SCHK Mainland China Companies Index, Hang Seng SCHK ex-AH Companies Index, and Hang Seng Small Cap (Investable) Index. For more information, please visit www.nissingroup.com.hk. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Bintai Kinden Posts 152% Rise in Revenue for 1Q ACN Newswire

Bintai Kinden Posts 152% Rise in Revenue for 1Q

August 26, 2022
PETALING JAYA, Malaysia, Aug 26, 2022 - (ACN Newswire via SEAPRWire.com) - Mechanical and electrical (M&E) engineering services specialist Bintai Kinden Corporation Berhad (Bursa: BINTAI, 6998) today announced that the Company registered a 152.0% increase in revenue to RM30.88 million for the first quarter ended 30 June 2022 (1Q FY2023) compared with RM12.26 million in the corresponding quarter of the previous financial year (1Q FY2022) mainly due to higher contribution from M&E engineering business.En. Azri Azerai, Executive Director of Bintai KindenBintai Kinden reported a profit after tax (PAT) of RM968,000 for the quarter under review, which is 23.0% lower than the PAT of RM1.25 million recorded in 1Q FY2022 as gross profit margin decreased to 16.45% from 30.0% after taking into account variation orders from completed M&E projects.The Company's M&E engineering business contributed RM26.43 million for 1Q FY2023, which is an increase of 203.72% compared with RM8.7 million in 1Q FY2022. The concession business brought in RM3.6 million, a marginal increase compared with RM3.55 million. Bintai Kinden operates the entire in-campus accommodation for Universiti Melaka as part of a 25-year concession from Kolej Teknologi Islam Melaka Berhad (KTIMB). As of 31 March 2022, KTIMB owes Bintai Kinden an outstanding sum of RM30.18 million from the concession.En. Azri Azerai, Executive Director of Bintai Kinden said, "We will continue to leverage on our core M&E engineering specialisation to seek opportunities in Malaysia and around the region. The surge in economic activities following the previous two years of intermittent lockdowns due to COVID-19 will definitely have positive spillover effects.""Through our indirect subsidiary, Johnson Medical International Sdn Bhd, we have a niche as a turnkey solutions provider of mobile, modular and offsite engineered healthcare infrastructure that we intend to expand and in which our M&E engineering services can also benefit. Through our 51%-owned subsidiary, Bintai Energy Sdn Bhd, we have been busy exploring opportunities to distribute flanges and other related piping products, the latest of which is a business collaboration agreement with PT Raintech Indo Energi."Bintai Energy has also recently been granted approval for a license by Petroliam Nasional Berhad under the Standardised Work and Equipment Categories Code, to bid for oil and gas (O&G) projects that come under Petronas. Bintai Kinden's orderbook covering M&E as well as O&G projects total RM120.43 million.Bintai Kinden Corporation Berhad: 6998 [BURSA: BKC], http://bintai.com.my/ Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Maxim: Society Pass (Nasdaq: SOPA) Raise Estimates on Expected Contributions from M&A, Positive on the South East Asia E-commerce Market ACN Newswire

Maxim: Society Pass (Nasdaq: SOPA) Raise Estimates on Expected Contributions from M&A, Positive on the South East Asia E-commerce Market

August 23, 2022
SINGAPORE, Aug 23, 2022 - (ACN Newswire via SEAPRWire.com) - Maxim Group LLC ("Maxim") issues Equity Research Report on Society Pass Inc. (Nasdaq: SOPA) ("SoPa").Click Here (on Society Pass website) to view the full Maxim Equity Research Report. https://tinyurl.com/Maxim-SOPASummary Points:- SOPA is in the early stages of building an online South East Asian company. Luxury store, Leflair, was the primary revenue contributor for 2Q22. Other businesses are food and beverage online support, online delivery companies Handycart and Pushkart (bought during 1Q22), and Mangan.ph (2Q22), as well as Gorilla Networks, a telecom MVNO (early June '22). SOPA is also starting a loyalty points offering. Maxim believes there should be significant cross-selling opportunities and organic growth in the future. Specifically, Maxim believes Thoughtful Media can market the Company's other brands and the food delivery and luxury brand businesses can be expanded geographically. Maxim has a positive view on the SEA market given faster-than-expected growth rates, increasing mobile and ecommerce penetration, younger populations, travel opening back up, and the opportunity to consolidate smaller companies.- 2Q22 revenue of $445K increased significantly from $8K in the prior year quarter, but was below our estimate of $670K. Results were held back as most of its businesses were very early stage. Almost all the quarter's revenue came from the online ordering segment, which currently consists of the company's online luxury store, Leflair. The cost of online marketing limited the amount put to use. Hardware and Software segments are currently not being prioritized. 3Q22 adjusted EBITDA loss of ($4.4M) was wider than our estimate of ($3.3M) and a loss of ($0.1M) in the prior year quarter. The variance vs. our estimate is primarily due to 1-time costs related to capital raises, M&A, higher growth investments, and public company-related costs.- Healthy cash. SOPA ended June 2022 with $28M in cash and no debt. Cash included the $25M, net from November 2021 IPO and $10.7M, net from a February 2022 capital raise. Maxim projects current cash levels to be sufficient to fund organic growth over the next two years.- Maxim raises revenue projections and expect significant growth for the next two years. Maxim expects growth from spending on marketing, expansions, and launch of Loyalty Points in mid-2022 and factoring in contributions from all announced acquisitions.- Maxim projects revenue to increase from $0.5M in 2021, to $12.9M in 2022 (unchanged), and $54M in 2023 ($38.2M prior). The increase is due to the significant expected contribution from acquisitions and organic growth. Maxim projects 2022 adjusted EBITDA loss to widen to ($13.9M) (($12.7M prior), from a loss of ($4.9M) in 2021. The higher loss is due to one time costs related to acquisitions and higher public company expenses. For 2023, Maxim projects the adjusted EBITDA loss narrows to ($2.2M) from ($4.7M) prior.- Compelling valuation - Maxim believes SOPA is undervalued and trades at a discount to its peer group. SOPA trades at an EV/revenue multiple of 0.4x our 2023 revenues compared to a peer group EV/revenue multiple of 2.3x our 2023 revenues. Maxim's positive outlook is supported by the attractive SE Asian markets and opportunities to consolidate smaller companies. Management has announced plans to spin off Leflair Group and to have it listed on the Nasdaq by the end of 2022.About Society Pass IncAs a digitally-focused loyalty and data marketing ecosystem in Vietnam, Indonesia, Philippines, Singapore and Thailand and with offices located in Angeles, Bangkok, Hanoi, Ho Chi Minh City, Jakarta, Manila, and Singapore, SoPa is an acquisition-focused e-commerce holding company operating 6 interconnected verticals (loyalty, lifestyle, F&B, telecoms, digital media, and travel), which seamlessly connects millions of registered consumers and hundreds of thousands of registered merchants/brands across multiple product and service categories throughout SEA.SoPa's business model focuses on analysing user data through its Society Pass loyalty platform and circulation of its universal loyalty points or Society Points. The Society Pass loyalty platform drives customer acquisition and increases customer retention for merchants. Since its inception, SoPa has amassed over 3.3 million registered consumers and over 205,000 registered merchants/brands onto its platform. It has invested 2+ years building proprietary IT architecture to effectively scale and support its consumers, merchants, and acquisitions.SoPa leverages technology to tailor a more personalised experience for customers in the purchase journey and to transform the entire retail value chain in SEA. SoPa operates Leflair.com, Vietnam's leading lifestyle e-commerce platform; Pushkart.ph, a popular grocery delivery company in Philippines; Handycart.vn, a leading Vietnam-based restaurant delivery service; Mangan, a leading local restaurant delivery service in Philippines; Gorilla Networks, a Singapore-based, web3-enabled mobile blockchain network operator; Thoughtful Media Group, a Bangkok-based, a social commerce-focused, premium digital video multi-platform network, and NusaTrip, a leading Jakarta-based online travel agency in Indonesia and across SEA. For more information, please check out: http://thesocietypass.com/.Media Contacts:PRecious Communicationssopa@preciouscomms.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion ACN Newswire

Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion

August 23, 2022
HONG KONG, Aug 23, 2022 - (ACN Newswire via SEAPRWire.com) - Sino Biopharmaceutical Limited ("Sino Biopharmaceutical" or the "Company", together with its subsidiaries, the "Group") (HKEX:1177), a leading innovation-driven pharmaceutical conglomerate in the PRC, has announced its unaudited Interim results for the six months ended 30 June 2022 (the "Period").Development Highlights-- The Group achieved considerable sales growth from a number of new products and oncology products, with sales of new products launched within five years accounted for approximately 43.5% of the Group's total revenue in the first half of 2022, up from approximately 36.9% for the same period last year.-- As of 30 June 2022, the Group had a total of 40 innovative drug candidates in the oncology field, 8 innovative drug candidates in the field of liver disease, 9 innovative drug candidates in the respiratory system field in development process for clinical application, and 1 innovative drug candidate in the field of surgery/analgesia in phase III clinical trial. Furthermore, the Group had a total of 23 biosimilar or generic drug candidates in the oncology field, 9 other biosimilar or generic drug candidates in the surgical/analgesic field, 5 biosimilar or generic drug candidates in the field of liver disease and 20 biosimilar or generic drug candidates in the respiratory system field in development process for clinical application.-- Focus V (Anlotinib Hydrochloride Capsules) was approved for the fifth indication-differentiated thyroid cancer in the first half of 2022. To date, Anlotinib has been approved for five indications: third-line non-small cell lung cancer, third-line small cell lung cancer, soft tissue sarcoma, medullary thyroid cancer and differentiated thyroid cancer.-- TDI01 is a highly selective inhibitor of ROCK2 and is currently in development process of phase I clinical trial for the target indications of pneumoconiosis, pulmonary fibrosis and graft versus host disease. There is no approved drug for pneumoconiosis worldwide, TDI01 is expected to fill this gap and be a boon to pneumoconiosis patients. -- SFT-1001 and SFT-1003 are two soft mist inhalation products that are currently in late clinical stage. As of 2021, there are only five soft mist inhalation products available worldwide, with a global market size of over US$3 billion and a compound growth rate of over 35% in the past five years, and the global soft mist market is expected to each US$7 billion by 2030.During the Period, the Group recorded revenue of approximately RMB15.19 billion, an increase of approximately 5.9% against last year. Profit attributable to the owners of the parent company was approximately RMB1.92 billion. Earnings per share attributable to the owners of the parent company were approximately RMB10.30 cents. Excluding the share of profits and losses of associates and a joint venture (net of related tax and non-controlling interests), certain non-cash items and one-off adjustments, adjusted non-HKFRS profit attributable to the owners of the parent was approximately RMB1.66 billion, an increase of approximately 4.5% over that in the same period last year. Sales of new products accounted for approximately 43.5% of the Group's total revenue for the period, while it was approximately 36.9% for the same period last year. The Group's liquidity remains strong, with cash and bank balances classified under current assets of approximately RMB7.77 billion, bank deposits classified under non-current assets of approximately RMB6.84 billion, and wealth management products of approximately RMB7.64 billion in aggregate, the Group's total fund reserve was approximately RMB22.25 billion at the period end.The Board of Directors has declared the payment of an interim dividend of HK6 cents per share. (2021: HK4 cents).Sales: Harvested years of R&D results, sales of new products as a percentage to revenue climbedThe Group has obtained significant benefits from years of high research and development, and continues to focus on development of related products in the areas of specialist therapeutic. During the period, the sales revenue of new products launched within five years was approximately RMB6.61 billion, accounting for approximately 43.5% of the total revenue of the Group from approximately 36.9% last year.During the Period, the Group's oncology, liver disease and cardio-cerebral vascular medicines continued to lead in sales contribution. Sales of oncology medicines increased by 16.7% year-on-year to approximately 4.96 billion, accounting for approximately 32.6% of the Group's revenue. Sales of liver disease (hepatitis) medicines and cardio-cerebral vascular medicines increased by approximately 11.1% and 13.8% year-on-year to approximately 2.01 billion and 1.55 billion, respectively, accounting for approximately 13.2% and 10.2% of the Group's revenue. In addition, the sales contributions of products in various areas such as surgery/analgesia, respiratory system and others went up hand-in-hand. Sales of surgery/analgesia and respiratory system medicines accounted for approximately 16.6% and 10.0% of the Group's revenue, respectively.In the area of oncology, since its launch in 2018, the revenue from sales of Anrotinib has continued to grow rapidly and is expected to grow at a compound rate of 46% in the period between 2018 and 2022. During the Period, sales of Annike (Penpulimab monoclonal antibody injection) increased significantly against the same period last year. F-627 (Efbemalenograstim alpha, long-acting granulocyte colony-stimulating factor) is currently under marketing application stage. It provides a safety advantage over mainstream second generation products currently on the market, is expected to be approved in China in the first half of 2023.In the area of surgery/analgesia, the Group focused on hospital access and high-potential area development, specifically on developing and increasing coverage of secondary hospitals and community healthcare facilities, driving the rapid growth of Debaian (Flurbiprofen) Cataplasms in the first half of the year.In the area of liver disease, the Group made efforts to strengthen academic promotion so as to expand doctor coverage and enhance expert recognition, as well as actively identified new patients and new market to develop, driving the rapid growth of sales revenue of Tianqing Ganmei Injection during the Period.R&D: Continued to focus on new products in specialist therapeutic areasThe Group has continued to focus R&D efforts on new oncology, surgery/analgesia, hepatitis, respiratory system and cardio-cerebral vascular medicines. As of 30 June 2022, a total of 418 pharmaceutical products had obtained clinical trial approval, or were under clinical trial or applying for production approval. Of them, 29 were for under hepatitis, 230 for oncology, 31 for respiratory system medicines, 9 for endocrine, 16 for cardio-cerebral medicines, 3 for surgery, 4 for analgesia and 96 for other medicines.Prospects: Two-pronged approach of independent research and development, focusing more on products with high innovation and market potentialIn the future, the Group will build a healthier, more diversified and sustainable revenue structure by continuing to build on traditional public hospital sales, invest more resources in new marketing channels and new marketing tools, and gradually expanding their share of revenue. In view of the potential impact of the national volume-based procurement policy on generic drugs, the Group has re-evaluated and optimised its product lines under development from the perspective of innovation and market value, focusing more on products highly innovative and with market potential.The Group will continue to invest more resources in innovative R&D facilities, personnel and projects. Innovation has become a key driver of growth for the Group, with the share of revenue from innovative medicines expected to reach 24% by 2022. Looking ahead, the Group plans to attain revenue exceeding the RMB10 billion mark from innovative medicines by 2023, further increasing the share of revenue from them in the Group's total. The Group aims to become a world-class innovative pharmaceutical group by 2030, with a revenue target of HK$100 billion, of which over 60% is expected to be contributed by innovative drugs.Looking ahead, the Group is focusing on four therapeutic areas, namely oncology, surgery/analgesia, liver disease and respiratory system, and will strive to achieve its 2030 target by adopting a two-pronged approach - pursuing independent research and development and innovation-driven business development.About Sino Biopharmaceutical Limited (HKEX:1177)Sino Biopharmaceutical Limited is a leading, innovative R&D-driven pharmaceutical conglomerate in the PRC. Its business encompasses a fully-integrated chain which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potential, comprising a variety of biopharmaceutical and chemical medicines for oncology, surgery/analgesia, hepatitis, and respiratory system.Sino Biopharmaceutical is a constituent stock of the following indices: MSCI Global Standard Indices - MSCI China Index, Hang Seng Index, Hang Seng China Enterprises Index, Hang Seng Composite Index, Hang Seng Healthcare Index, Hang Seng SCHK Mainland China Healthcare Index, Hang Seng Composite LargeCap Index, Hang Seng Composite LargeCap & MidCap Index, Hang Seng China (Hong Kong-listed) 100 Index and Hang Seng Stock Connect Hong Kong Index, etc.. Sino Biopharm was ranked as one of "Asia's Fab 50 Companies" by Forbes Asia for three consecutive years in 2016, 2017 and 2018. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
JPEX officially launches JPC against the bearish market. SeaPRwire

JPEX officially launches JPC against the bearish market.

August 15, 2022
New York, NY, August 15, 2022 – (SEAPRWire) – JPEX, a centralized crypto exchange, has officially launched its native asset, JPC. Launched at 8 PM on August 8th, 2022, JPC saw a 200x surge in price and over 500 million in volume. According to data from JPEX, this recently released native asset initially traded at $0.00001, then moved up to $0.0021 in the later hours. At press time, JPC trades at $0.00117, a 0.66% increase in the last hour and a trading volume of $25 billion in the previous 24 hours. JPC was first listed on JPEX on July 27th, and an investment round ensued, raising over $27 million with over 100k subscribers, a groundbreaking feat in the exchange-backed token space. As part of the JPEX team’s plan to incentivize potential token holders, the centralized exchange, in a recent announcement, stated it would issue over 500k JPC tokens [worth $550 at press time] to users who complete the know-your-customer [KYC] verification on or before April 10th, 2022. JPC Token Use Cases and Application JPC is an ERC-20 token standard, and its application includes; a transaction fee waiver, relevance in the JPEX game center, will serve as a reward for the JPEX Friend Program, and will possess staking powers. JPC will additionally power the JPC Community Development Program and act as a governance token of the JPEX community. NFT and Metaverse trading discounts and exclusive offerings, asset insurance increments, and the prospects of new listings are also use cases of the JPC native token. According to the JPEX team, earnings from JPC token sales will go to the repurchase of the token and, subsequently, destruction. With a firm determination to delivering a comprehensive platform for users globally, JPEX, via an Instagram post, announced that Julian Cheung, popularly known as Chilam, a renowned Hong Kong singer and actor, will become an ambassador of the centralized crypto exchange. The signing of The Grandmaster actor is proof of the lengths JPEX is willing to go to further advance the brand and the native asset, JPC. Julian Cheung’s appointment as brand ambassador aims to promote the launch of JPC. About JPEX JPEX is one of the most accessible centralized exchanges for quick, transparent, and legitimate buying and selling of cryptocurrencies. With millions of users, the launch of JPC as a native token will further cement the platform’s stance as one of the market leaders. JPC will introduce essential features to the exchange, attracting more users and retaining existing customers. For PR Inquiry, please contact info@finpr.agency, https://finpr.agency Social Links Twitter: https://twitter.com/ExchangeJpex Instagram: https://www.instagram.com/jpex_official/ Telegram: https://t.me/jpexannouncement Facebook: https://www.facebook.com/JPEX-Exchange-100535999063470 Discord: https://discord.gg/3CZmeZ9m Media Contact Brand: JPEX Contact: Media team E-mail: cs@jp-ex.io Company Website: https://jp-ex.io/ SOURCE: JPEX The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
More
600+ cybersecurity experts meet at PhilSec 2022 to discuss the future of cybersecurity in the Philippines ACN Newswire

600+ cybersecurity experts meet at PhilSec 2022 to discuss the future of cybersecurity in the Philippines

August 11, 2022
MANILA, Aug 11, 2022 - (ACN Newswire via SEAPRWire.com) - In an effort to mitigate the cybercrime landscape in the Philippines and support The Department of Information and Communications Technology with its efforts, Tradepass hosted the second edition of PhilSec on 12 - 13 July 2022 at the Sofitel Philippine Plaza in Manila, Philippines. The event that was officially supported by Cybercrime Investigation and Coordinating Center (CICC) attracted 600+ cybersecurity experts including the Heads of Information Security, Risk, Compliance, Forensics and Cyber Law from the leading public and private enterprises across the Philippines. Mary Rose E. Magsaysay (C|CISO, Director IV - Cybercrime Planning and Policy, Monitoring and Cooperation Office - Cybercrime Investigation and Coordination Center) who is also the in charge & lead at ICCD, CPPD & CMCD graced the opening of the event post an engaging flashmob.Here's what she had to say when talking about her experience at PhilSec 2022, "This is my first time back on-stage post pandemic. My expectations were really high and they were met excellently and not just satisfactorily. I was surprised to see the number of vendors who I got to interact with. I was surprised to see that there were a lot of delegates representing DICT, CICC and I saw a very good mix of audience."With the most carefully curated agenda that comprised advanced topics in cybersecurity, PhilSec 2022 also hosted over 40 of the best cybersecurity experts and thought leaders who had a spellbinding effect on the delegates with their knowledge sharing sessions. When asked to share his overall thoughts on the event, Carlos Tengkiat (CISO, Rizal Commercial Banking Corporation) expressed, "PhilSec is actually very good because it brings people together to collaborate and also the industry players to showcase their solutions which can secure our infrastructure and keep us in line with the new developments in technology and security."As the country's premier cybersecurity event, PhilSec 2022 was flooded with the leading organizations from the industry who had their exclusive exhibition booths at the venue to showcase their cutting-edge security solutions. The long list included Delinea, ARCON, Okta, Recorded Future, CrowdStrike, CyberArk, Rubrik, ExtraHop, BlueVoyant, Claroty, BeyondTrust, Synology, Tenable, Parasoft, Swimlane, CybersCool Defcon Inc., Senhasegura, ThriveDX SaaS, DDLS, Sangfor Technologies, Netskope, CYFIRMA, ION Management Solutions Inc., Noname Security, IPV Network, Cyberint and Secuna.Noel Cuestas (Chief - Audio, Video Forensic Section, Digital Forensic Unit - Philippine National PoliceAnti Cybercrime Group) while talking about his experience at PhilSec 2022 commented, "This is my first time at PhilSec and I must say that this has been very fascinating. This is a good area for networking and meeting a lot of friends in the industry, from cybersecurity, digital forensics and other law enforcement officers are also here, so this is an excellent venue."The event featured two knowledge-packed days filled with insightful presentations on the most pressing industry topics, deep dive panel discussions, live showcase of the best security solutions and abundant networking opportunities. Some of the crucial topics from the summit include: "Cyber Defense for Philippine's Critical Infrastructure", "Zero Trust: Two Sides of the PAM Coin", "How Cybercriminals Use Dynamic DNS Infrastructure for Advanced Attacks", "Web 3.0: Unravelling Unknown Unknowns", "Digital Forensics" and many more."The way the whole event is planned and organized is actually really nice, it has a very good selection of speakers and the different topics that the event wants to showcase caters to the industry really well," said Mel Migrino (Vice President and Group CISO, Meralco) while taking about the organization of the event.Apart from the knowledge sharing and networking sessions, PhilSec 2022 also acknowledged the top talents from Philippines' cybersecurity during the awards segment, PhilSec Awards 2022. The event stayed completely vibrant over the course of two days through flash mobs, dance performances, a show by Manila's best illusionist and a swanky after-party for added networking exposure.For more information about the event, log on to:https://philsecsummit.com/About TradepassProviding access to the global emerging markets, Tradepass brings together people, products and solutions to power events for unparalleled business and networking opportunities. Being the most accredited event company, it helps organizations: enter new markets, grow sales pipeline, close prospects, raise capital and identify the right solution-providers.As a deal facilitator, Tradepass is always determined about exposing the most agile liquid growth markets, to enable all-round scalability and growth.Media contact:Aritrika ChakrabortyMarketing Manageraritrikac@tradepassglobal.com+ (91) 80 6166 4401Tradepass Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Corinium Presents: CISO Singapore ACN Newswire

Corinium Presents: CISO Singapore

August 3, 2022
Singapore, Aug 3, 2022 - (ACN Newswire via SEAPRWire.com) - Corinium's Chief Information Security Officer (CISO) Singapore gathers the region's leading information security executives to share their insights on ransomware, threat intelligence, threat hunting, cloud security, emerging technology risk and more. For 2022 we are celebrating our first in-person CISO event in Asia by showcasing the progress made, offering insights and effective IT security strategies to the challenges that remain and preparing for the challenges that have yet to be unveiled.Tailored sessions to get the most out of your time at CISO Singapore, from dedicated use case presentations to off-the-record extended Q&A sessions with international speakers and a deep-dive into robust infosec strategies, ideas and discussion. Take part in the premium regional meeting place with expert and renowned leaders internationally and from Singapore to benefit your own leadership journey with C-level discussions and thought leadership.2022 Key Themes:CISO LEADERSHIP: staying one step ahead of constant changeTHREAT INTELLIGENCE: keeping pace with current adversariesPEOPLE: improving cybersecurity culture and awarenessREMOTE WORK & OPERATIONS: safeguarding the future with confidenceIDENTITY MANAGEMENT: strengthening access control, IAM, PAM, federated identityMIND THE GAP: adopting effective incident planning and vulnerability testing and assessmentGOVERNANCE & COMPLIANCE: breaking through complexityCLOUD SECURITY: how to protect data, applications and infrastructureSUPPLY CHAIN THREATS: managing of your digital assets and services risksIOT SECURITY: what it means to businesses and risks involvedCYBERCRIME: Notable trends 2022 and beyond.Register Today! Discover what cybersecurity trends you need watch in 2022 and beyond! Find out what the Singapore Government is doing to overcome the challenges digital trust, and learn how your peers are gaining company-wide support for their cybersecurity strategies!For Further details regarding this event, visit our websitehttps://ciso-sing.coriniumintelligence.com You can contact us at: info@coriniumintel.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Eisai to Present at The Alzheimer’s Association International Conference (AAIC) 2022 JCN Newswire

Eisai to Present at The Alzheimer’s Association International Conference (AAIC) 2022

July 26, 2022
TOKYO, Jul 26, 2022 - (JCN Newswire via SEAPRWire.com) - Eisai Co. Ltd announced today that the company will present research from its Alzheimer's disease (AD) pipeline, including new data for lecanemab (BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD (collectively known as early AD) with confirmed presence of amyloid pathology in the brain, at the Alzheimer's Association International Conference (AAIC) to be held in San Diego, CA and virtually from July 31 to August 4, 2022. Eisai will present data and research in three oral and 18 poster presentations at the meeting.On July 5, 2022 (U.S), Eisai announced that the U.S. Food and Drug Administration (FDA) accepted the Biologics License Application (BLA) for lecanemab under the accelerated approval pathway and was granted priority review, with a Prescription Drug User Fee Act (PDUFA) action date of January 6, 2023. The readout of the primary endpoint data of Clarity AD will occur in the Fall of 2022. The FDA has agreed that the results of Clarity AD when completed, can serve as the confirmatory study to verify the clinical benefit of lecanemab.Key Eisai AAIC Presentations- Effect of Genotype on ARIA-E Incidence by Lecanemab: Results from a modeling simulation to evaluate the effect of APOE4 genotype on ARIA-E incidence from study 201 Core and comparison to the observed incidence in the open-label extension among those newly treatedwith lecanemab. (Virtual Developing Topics #69402) - Lecanemab Subcutaneous Dosing:Results from a study in healthy subjects to evaluate the absolute bioavailability, pharmacokinetics, safety, and immunogenicity of lecanemab following a single fixed 700 mg subcutaneous dose. (Poster/Abstract #69438)Modeling and simulation analysis aimed at showing the equivalence of fixed weekly subcutaneous dose of lecanemab to body weight-based 10mg/kg biweekly intravenous dose. (Poster/Abstract #69429)- Ethnic and Racial Diversity in Eisai Clinical Trials: An evaluation of US enrollment across lecanemab (Study 201 and Clarity AD) and elenbecestat MissionAD studies in early AD to assess racial and ethnic groups and the impact of eligibility criteria in the United States. (Poster/Abstract # 69198)- Beta-Amyloid Assays Predict Brain beta-Amyloid Pathology: Data from the Eisai and Sysmex collaboration reporting on the fully automated plasma Abeta40 and Abeta42 immunoassays and their performance for predicting brain Aβ pathology defined by amyloid PET. (Poster/Abstract # 68727) - Comprehensive CSF Tau Profiling from Dominantly Inherited Alzheimer Network (DIAN): An oral presentation that shares results from a study in patients enrolled in Washington University School of Medicine's DIAN-observational cohort that used Eisai's anti-microtubule binding region (MTBR) antibody, E2814, to profile MTBR-tau and then assessed timing to MTBR-tau changes in CSF and correlation to clinical, cognitive, and biomarker changes. (Oral Presentation # 65313)"The lecanemab data Eisai will present at AAIC 2022 continues to build the body of knowledge about our investigational anti-amyloid beta protofibril antibody as we work toward the Phase 3 confirmatory Clarity AD readout this fall," said Michael Irizarry, M.D., Senior Vice President, Deputy Chief Clinical Officer, Alzheimer's Disease and Brain Health, Eisai Inc. "Additional research presented will highlight Eisai's efforts to improve ethnic and racial diversity in our early Alzheimer's disease clinical trials in the United States so that study populations mirror the U.S. Medicare population, as well as research from our collaboration with Sysmex on potential biomarkers that may contribute to early diagnosis of Alzheimer's disease."For more information, visit https://www.eisai.com/news/2022/pdf/enews202257pdf.pdf. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
The Iron Women of Western China SeaPRwire

The Iron Women of Western China

July 19, 2022
Beijing, China, July 19, 2022 - (SEAPRWire) - "I think I'm thoroughly a feminist," said Aya, who happened to see the news of the abolition of the Abortion Law in the United States while traveling through the bustling crowds in the ancient city of Kashgar "Women, wherever they are, should have equal rights with men." Although she comes from a traditional Muslim family in Africa, Aya seems to be gradually "awakening", finding ways to nurture the impulse to struggle against a male dominated world. Her first "struggle" was in 2018, when she attended Zhejiang Normal University, thousands of miles away from home, to study Chinese, despite her father's strong opposition. The second "struggle" was to participate in the school-organized field trip to learn about life in China's less developed areas. Her mother was frightened when she learned that her daughter was going to Xinjiang, because she had heard a lot of negative information about the region, "You will be arrested", her mother cried and begged Aya to cancel the trip. She understood her mother's concerns, but she still chose to attend the field trip if only to discover those ordinary women in rural Chin who were also "fighting" against a male dominated society. In the Performance Hall of the Xinjiang Art Theater in Urumqi, Aya met Guli, who, wearing traditional Uyghur dance clothes, performed the Dance of the Twelve Muqams. Guli loves to dance and practices in the palace-like building everyday. Guli says that dancing in the elegant theatre makers her feel like a princess and she longs to be on stage forever. At 28 years old, Guli is in the prime of her career. However, her parents and husband constantly urge her to have children as soon as possible. Stressed deeply by these expectations, she is constantly balancing her beloved career and family. In the end, she reached a compromise with her husband. "I will continue dancing for three years, devote these precious years to my career. After that, I will look to start a family with my husband," Guli told her classmates. "I am working hard to practice Chinese. In the future, I plan to move to Shanghai to open a workshop and teach children to dance. I can make money and continue my love of dancing!" Wearing a white headscarf and a traditional skirt, Aparhan sat at the door of her old house in the ancient city of Kashgar. Against the backdrop of the sunset, she herself seemed to become interwoven with the well-preserved traditional style buildings, some more than a thousand years old. Looking at the tourists passing by from time to time, Aparhan's mind is conflicted. She doesn't like seeing young girls wearing modern skirts, nor their makeup and strange hairstyles. She pleads with her granddaughters, "This is not our tradition", but in vain. Her granddaughters like to show off their beauty. Economic development has not only greatly improved her material life, but also brought its share of troubles. Secularism made a huge impact on the traditional moral order. Aparhan sometimes feels powerless to struggle against it. Meeting Pattiman was a story filled with romance, remembers Aya. At night, Kashgar sees a barrage of vendors flooding the streets, loudly soliciting their business. Except that people were wearing masks, no other effects of the pandemic could be felt, let alone the so-called security problems. Aya felt her mother's worries were overblown. Nazar, a male classmate of hers from Turkmenistan, tall and handsome, attracted significant attention from the passersby. Locals were asking for group photos, and Pattiman was by far the boldest one. She was pretty, with long flowing hair. She stopped Nazar and invited him to drink juice in a nearby bar. The hearts of the handsome boy and the beautiful girl from two different countries collided. They communicated freely and warmly in both Chinese and English, discussing everything, from their majors to their favorite movies. Nazar boldly invited Pattiman to go to Turkmenistan for a visit. Pattiman said, "I used to study at Tianjin University. Because of my father's request, I had to return to my hometown to work after graduation. But now I regret my decision, as the outside world is so exciting. I'd love to go and find you in your country." Around the world, modern women are facing constraints and pressures from society, family and tradition. Some are compromising, some are struggling, and some are practicing the long art of reform. In Aya's view, the women she met while traveling were lucky. They had a fierce independent streak to their personalities and were self-confident despite the rapid development of society around them. They freely displayed their feminine side and expressed their likes and dislikes, freely choosing to accept or reject what they please. Despite each of their individual hardships, they held and status and respect in each of their respective "struggles". The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
More
Renowned authors speak at HKTDC Hong Kong Book Fair ACN Newswire

Renowned authors speak at HKTDC Hong Kong Book Fair

July 15, 2022
HONG KONG, Jul 15, 2022 - (ACN Newswire via SEAPRWire.com) - The 32nd HKTDC Hong Kong Book Fair, organised by the Hong Kong Trade Development Council (HKTDC), is once again holding the popular "Eight Seminar Series", with highlights this year including the "Renowned Writers Seminar Series", co-organised by Ming Pao and Yazhou Zhoukan, and the "English and International Reading Series", supported by Book Depository. This year's Book Fair, which runs from 20 to 26 July (Wednesday to Tuesday) at the Hong Kong Convention and Exhibition Centre (HKCEC) under the theme "History and City Literature", has invited acclaimed local and foreign writers to speak at a series of virtual and in-person seminars, sharing the challenges and triumphs they face during their writing journey.The “Renowned Writers Seminar Series” is honoured to invite Liu Zhen-yun (L), winner of the Mao Dun Literature Prize, and Sisy Chen (R), a famous Taiwanese author and television host, to be guest speakers.Clare Mackintosh (Photo credit: (c) Bill Waters) Gillian McAllister (Photo credit: (c) Bill Waters)The "Renowned Writers Seminar Series" is honoured to invite Liu Zhen-yun, winner of the Mao Dun Literature Prize, and Sisy Chen, a famous Taiwanese author and television host, to be guest speakers. Mr Liu will introduce his latest work, Laughter and Tears: A Novel, while Ms Chen will analyse the direction society is taking in a seminar titled "In the 21st Century, We Go from Civilisation to Barbarism". Other authors in the star-studded line-up include Zhou Guo-ping and Zhi An from Mainland China; Sun Sai-shing, Li Pi, Johnson Chang, Liu Heung-shing, Xu Zi-dong, Ho Fuk-yan and Nicole Huang from Hong Kong; Xie Yong-mao and Bo-Chow Lan from Taiwan; and Honda Yoshihiko from Japan.The "English and International Reading Series" will invite a number of famous English- and foreign-language writers to speak about their fascinating writing journeys, including British author Clare Mackintosh and Sunday Times Top 10 bestselling author Gillian McAllister. Translated into more than 40 languages, Clare Mackintosh's books have sold more than two million copies worldwide and won numerous awards. Among the other speakers are Simon Toyne, Mio Debnam, Mark O'Neill and Maisie Chan. Hong Kong's booklovers will be able to experience different cultures and broaden their horizons through the sharings of these acclaimed authors.Liu Zhen-yun - Laughter and Tears: A NovelBorn in Yanjin in Henan Province, Liu Zhenyun started his writing journey at Farmer's Daily after graduating from the Chinese faculty of Peking University. His style is neo-realism and he writes with a signature sense of humour, and with an emphasis on his hometown in his works. From Someone to Talk To, Ground Covered with Chicken Feathers, Remembering 1942 to I Did Not Kill My Husband, most of his books reflect the hardships people encountered in the past but in a humorous way, depicting a vivid portrayal of community life.Mr Liu believes the underlying meaning of comedy is sharing pain. His just-published book Laughter and Tears: A Novel is a work of black humour, which he summarises as: "one should take encounters in life as jokes and laugh them off". The book is based on the idea of "jokes", which the author sees as an effective tool to examine the nature of humanity. Many jokes connect people from different groups, areas and nations. The new book enriches the "Yanjin World" constructed in Mr Liu's previous novels, and fans are eagerly looking forward its unveiling at the Book Fair.Sisy Chen - from civilisation to barbarismSisy Chen, Jaw Shaw-kong and Li Ao form the famous triumvirate of political commentators in Taiwan. Ms Chen, well known for her multifaceted talents, is a celebrated academic, TV host, radio host, writer and art curator. These diverse experiences empower her with knowledge, wisdom and vision along with accomplished writing skills. Her works cover a wide swathe, including global finance, international politics, short essays, women and love, reflections on life and philosophical speculation. Two of Sisy Chen's short stories, Only One Corner of Prosperity is Left and Tree is Gone, explore international politics and economics with advice for young people on how to handle adversity with fortitude. This dialogue is concluded in I'm Afraid of Success and I Believe in Failure, illuminating the way forward for the next generation.Ms Chen encourages readers to reflect more on international society and history through her words. "Reviewing the past and looking into the future, you should think more about whether we have retrograded from civilisation to barbarism, or if we have become more civilised," she once said. After going through the pandemic and reflecting on its impact, Ms Chen will share her insights into the post-COVID world with readers.Clare Mackintosh - from crimefighter to crime writerClare Mackintosh is the multi-award-winning author of five bestselling novels - I See You, I Let You Go, Let Me Lie, After the End, and Hostage - which were listed on the bestselling books list of the New York Times and USA Today and topped the Sunday Times bestseller list for 64 weeks. Her latest thriller, Hostage - a locked-room thriller set on a 20-hour flight - has just been released. Ms Mackintosh worked in the police force for 12 years and was once Thames Valley Police's operations inspector for Oxfordshire and town sergeant of Chipping Norton before becoming a full-time writer.I Let You Go, Clare Mackintosh's top-selling book, describes a hit-and-run accident that kills a lively five-year-old boy. Police Officer Gray and her team take over the investigation and solve the case without any witnesses or clues. In the coming Book Fair seminar session, the author will share her journey from law enforcement officer to crime fiction writer.Gillian McAllister - how to get and stay publishedRising British author Gillian McAllister was a lawyer before debuting in the book world in 2017. All her works, including Everything But the Truth, Anything You Do Say, No Further Questions, The Evidence Against You, How to Disappear, That Night, and the just-published Wrong Place Wrong Time, are bestsellers. Her debut novel, Everything But the Truth, appeared in the Sunday Times bestseller list at No. 6 in the very first week after publication. Another book, That Night, was recommended as a must-read by the well-known British TV show, Richard and Judy Book Club.Gillian McAllister's work has been published in 10 countries. All her novels are standalones and can be read in any order. She will be participating in the Hong Kong Book Fair for the first time, sharing the driving force behind her successful journey as an author.For more information on the full line-up of seminars and authors at the Book Fair, please refer to the links in the profile below. Interested readers may also visit the Hong Kong Book Fair website (www.hkbookfair.com) to register for free seminars and browse through more details of the fascinating events lined up for this year's event.Note: media representatives who wish to interview the guest speakers should email the interview format, outline and contact information on or before July 18 to ayiu@yuantung.com.hk.Websites- Hong Kong Book Fair: http://www.hkbookfair.com- Hong Kong Sports and Leisure Expo: https://hksportsleisureexpo.hktdc.com- World of Snacks: https://worldofsnacks.hktdc.com- Education & Careers Expo: https://hkeducationexpo.hktdc.com- Photo download: https://bit.ly/3uEWRuL- Photos of the exhibits, key speakers and other Book Fair highlights can be found at: http://bitly.ws/sJtkAbout HKTDC The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Follow us on Twitter @hktdc and LinkedInMedia enquiriesHong Kong Book FairHKTDC's Communications & Public Affairs Department:Clementine Cheung, Tel: +852 2584 4514, Email: clementine.hm.cheung@hktdc.orgSunny Ng, Tel: +852 2584 4357, Email: sunny.sl.ng@hktdc.orgSam Ho, Tel: +852 2584 4569, Email: sam.sy.ho@hktdc.orgYuan Tung Financial Relations:Agnes Yiu, Tel: +852 3428 5690, Email: ayiu@yuantung.com.hkHing-Fung Wong, Tel: +852 3428 3122, Email: hfwong@yuantung.com.hkHong Kong Sports and Leisure Expo, World of SnacksHKTDC's Communications & Public Affairs Department:Frankie Leung, Tel: +852 2584 4298, Email: frankie.cy.leung@hktdc.orgYuan Tung Financial Relations:Tiffany Leung, Tel: +852 3428 2361, Email: tleung@yuantung.com.hk Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Double Monza podium for TOYOTA GAZOO Racing JCN Newswire

Double Monza podium for TOYOTA GAZOO Racing

July 11, 2022
TOKYO, Jul 11, 2022 - (JCN Newswire via SEAPRWire.com) - TOYOTA GAZOO Racing earned a dramatic double podium finish in the 6 Hours of Monza after an exciting but ultimately frustrating fourth round of the 2022 FIA World Endurance Championship (WEC).Both GR010 HYBRIDs were strong contenders for victory in an incident-packed race at the Temple of Speed, but suffered misfortune in the heat of Hypercar competition.Fresh from their Le Mans 24 Hours win, Sebastien Buemi, Brendon Hartley and Ryo Hirakawa overcame an early technical issue on their #8 GR010 HYBRID to finish second, only 2.762secs behind the winning #36 Alpine.Last year's Monza winners, Mike Conway, Kamui Kobayashi and Jose Maria Lopez in the #7 GR010 HYBRID, were leading when they lost time following contact with the Alpine. The reigning World Champions finished third, two laps behind.A spectacular race among four Hypercar manufacturers leaves both World Championships wide open going into the final two races. TOYOTA GAZOO Racing leads the manufacturers' standings by 15 points from Alpine, while the #8 crew are second in the drivers' rankings, 10 points behind their Alpine counterparts.The two GR010 HYBRIDs were part of a close race from the very beginning. After a clean start, Sebastien drove brilliantly to hold second place under pressure from Alpine, while Jose was close behind in fourth.Two full course yellows in the opening 30 minutes saw all Hypercars make fuel stops. Smart strategy elevated Sebastien into second and Jose into third, although they were unable to challenge the race-leading Glickenhaus.Late in the first hour, Sebastien's race was interrupted by an electrical issue. He managed the issue well but could not avoid dropping two positions on track, including losing second to Jose. A system reset at his next scheduled pit stop cost 30 seconds and put him fifth but the car was back on the pace and Sebastien overtook Peugeot #94 for fourth.A full course yellow around one-third distance triggered the next pit stops. Mike took over the #7 car and diced for second place with the Alpine, while Brendon resumed in the #8.The complexion of the race changed after two-and-a-half hours when an accident from a GT competitor necessitated a safety car and closed up the field. All Hypercars pitted and Mike overhauled the Glickenhaus for the lead, thanks to a shorter pit stop.When the race resumed at half distance, Brendon moved into second when Glickenhaus served a drive-through penalty for a speeding infringement. He held position until the next pit stops, despite a sustained challenge from the Alpine.The top three Hypercars were separated by only a few seconds going into the final two hours and the positions alternated at each pit stop as a result of TOYOTA GAZOO Racing and Alpine changing tyres at different intervals.Towards the end of the fifth hour, with Kamui leading a GR010 HYBRID one-two, Ryo heroically held off the Alpine, which was on fresher tyres, for several laps before dropping to third on lap 153. A lap later, Kamui was defending the lead on the start-finish straight when the #7 and the Alpine made contact.The #7 sustained a right rear puncture and damage to its bodywork, and Kamui returned slowly to the pits for repairs. Thanks to a full course yellow, he lost only one lap and returned in third. When racing resumed with an hour remaining, Ryo was second and putting pressure on the race leader.Ryo showed impressive speed, as well as skill through the traffic, to keep the pressure on and he closed to within three seconds at the chequered flag. Kamui, who served a 90-second penalty as a result of the incident with the Alpine, took the flag in the #7 in third, two laps behind.TOYOTA GAZOO Racing therefore travels to the 6 Hours of Fuji with a point to prove, intent on returning to winning ways in its home race. The team has won seven of its eight races at Fuji Speedway and expects to challenge for another victory on 11 September in the penultimate round of the 2022 season.For more information, visit https://toyotagazooracing.com/wec/release/2022/rd04-race/. Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
SinoMab Received the Highest Subsidy from HKSTP ACN Newswire

SinoMab Received the Highest Subsidy from HKSTP

July 8, 2022
HONG KONG, Jul 8, 2022 - (ACN Newswire via SEAPRWire.com) - SinoMab BioScience Limited ("SinoMab" or the "Company", together with its subsidiaries, the "Group", stock code: 3681.HK), a Hong Kong-listed biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of innovative therapeutics for the treatment of immunological diseases, primarily mAb-based biologics, is pleased to announce that, the Company has received HK$8 million subsidy from the Hong Kong Science and Technology Parks Corporation ("HKSTP"), which is the highest subsidy amount in the Clinical Translational Catalyst (CTC) program of HKSTP.CTC program is offered by HKSTP Institute for Translational Research (ITR), the overarching aim is to provide a platform to transform Hong Kong and Greater Bay Area to become the go-to destination for translational medicine in the region. Under this program, funding support will be provided to biomedical companies of HKSTP to bring innovative, life-changing therapies and technologies to patients.SinoMab stood out from many biopharmaceutical companies in the CTC program and was granted the highest subsidy amount, embodying the recognition by the evaluation committee on the Company's product candidates and research and development (R&D) plan. According to the agreement signed by both parties, HKSTP will provide SinoMab a subsidy of HK$8 million in the next 42 months in phases according to its clinical plan and progress for the clinical study of SN1011, the Company's key product, for the treatment of multiple sclerosis (MS). SN1011 is SinoMab's key product and third-generation covalent reversible Bruton's tyrosine kinase (BTK) inhibitor. Following the approval of Investigational New Drug (IND) applications of SN1011 for systemic lupus erythematosus (SLE) and pemphigus vulgaris (PV) by the National Medical Products Administration (NMPA) on 27 August 2020 and 23 June 2021, respectively, the IND application of SN1011 for MS has been approved by the NMPA on 19 April 2022. The Company plans to initiate Phase II clinical study to evaluate the efficacy and safety of SN1011 in patients with MS in China and expects to enroll the first patient in the fourth quarter of 2022. The IND application of SN1011 for neuromyelitis optica spectrum disorder (NMOSD) was also accepted by the Center for Drug Evaluation (CDE) of the NMPA on 6 June 2022.Dr. Shui On LEUNG, Chairman, Executive Director and Chief Executive Officer of SinoMab said that: "By launching the CTC program, HKSTP provides great support to local biopharmaceutical companies on their New Drug R&D. As a biopharmaceutical company raised in Hong Kong for 20 years, we are grateful for the long-term support and assistance of the HKSTP in promoting innovation and development of local biopharmaceutical companies. Previously, President Xi Jinping, and the Chief Executive of the HKSAR, Mr. Lee Ka-chiu, visited the Science Park, with the desire to forge Hong Kong into an international Innovation and Technology hub, demonstrating the country's high appreciation of Hong Kong innovative technology development. We are excited by the unprecedented opportunities. With the smooth progress of clinical trials of the Company's key candidates, the subsidy from the HKSTP will provide a solid foundation for the Company's continuous R&D and stepping toward commercialization. We will fully grasp the opportunity to accelerate the R&D and clinical trials of various products, further expand the product pipeline and potential indications, speed up the realization of product commercialization, adhere to the concept of independent innovation, strive for the well-being of patients and create value for shareholders."About Hong Kong Science and Technology Parks CorporationEstablished in 2001, HKSTP attracts and nurtures talent, accelerates and commercializes innovation and technology for entrepreneurs on their journey of growth in Hong Kong, to the Greater Bay Area, Asia and beyond. Its growing innovation ecosystem is built around its key locations of the Hong Kong Science Park in Shatin, InnoCentre in Kowloon Tong and three modern INNOPARKs in Tai Po, Tseung Kwan O and Yuen Long. The three INNOPARKs are realizing a vision of re-industrialisation for Hong Kong. The goal is sectors like advanced manufacturing, electronics and biotechnology are being reimagined for a new generation of the industry. Through its infrastructure, services, expertise and network of partnerships, HKSTP will help establish innovation and technology as a pillar of growth for Hong Kong, while reinforcing Hong Kong's international I&T hub status as a launchpad for global growth at the heart of the GBA innovation powerhouse.About SinoMab BioScience LimitedSinoMab BioScience Limited (stock code: 3681.HK) is dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases. The Company's flagship product SM03 is a potential global first-in-target mAb against CD22 for the treatment of rheumatoid arthritis (RA) and is currently in Phase III clinical trial for RA in China, which has been recognized as one of the significant special projects of Significant New Drugs Development of the Twelfth Five-Year Plan Period and the Thirteenth Five-Year Plan Period. In addition, the Company possesses other potential first-in-target and first-in-class drug candidates, some of which are already in clinical stage, with their indications covering rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), pemphigus vulgaris (PV), non-Hodgkin's lymphoma (NHL), asthma, and other diseases with major unmet clinical needs. Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
MetaBitcoin (MBTC) Announces Investment from Alawad Fund SeaPRwire

MetaBitcoin (MBTC) Announces Investment from Alawad Fund

July 8, 2022
Dubai, UAE, July 8, 2022 – (SEAPRWire) – Recently, MetaBitcoin (MBTC), which implements all Bitcoin ecosystems identically within the Metaverse ecosystem, was selected as the first investment destination for the Alawad Fund. MetaBitcoin (MBTC) was issued by Meta Satoshi Nakamoto, and has the same elements as Bitcoin, 21 million total supply, 4-year halving, and mining compensation, can be purchased within. “Alawad Fund,” was launched on March 26 (local time) in Dubai, which is attracting attention as a “The holy land of crypto companies.” The fund was established as a joint venture between Sheikh Alawad and CEO jojo jiang, and announced that it plans to invest heavily in fostering the crypto industry. The first fund of “Alawad Fund” is a total of $300 million and will be operated with the goal of quant investment, virtual asset and block chain-based startup investment, cryptocurrency exchange investment, and cryptocurrency cultural content investment with a focus on bitcoin mining is expected. At the fund establishment ceremony, Alawad Fund’s jojo said, “Bitcoin (BTC) is difficult to mine, there are many restrictions such as electricity bills and mining farms, and there are currently only 2 million mining volumes left. It has a high barrier to entry.” She said, “It is difficult to rise more than several dozen times within a short period of time from now, but on the other hand, MetaBitcoin (MBTC) can be mined easily by anyone, and Bitcoin causes environmental problems. It is also free from the issue of being able to do it,” she said. She also stated, “MetaBitcoin (MBTC) was selected as the primary project of the Alawad Fund because of its low initial entry barrier and high evaluation of the fairness that both project sides and users start mining fairly.” MetaBitcoin started mining on May 3, and currently about 30,000 miners are participating in mining. Also from July 3rd, the upgraded miners from 500,000 to 2 million hashrate will be sold in three units. Dubai, United Arab Emirates (UAE) has recently become known as a hub for virtual assets and blockchain-based startups. While the government is attracting foreign talent through friendly policies at the government level, many crypto companies such as Binance are flocking to Dubai and emerging as a ‘holy land for crypto companies’. “Alawad Fund”, is famous in the blockchain by investing in promising projects with various key blockchain partners. Alawad Fund aim to grow as a promising fund. Sheikh Alawad said at the Alawad Fund inauguration ceremony on this day, “Dubai is presenting the most friendly business environment for blockchain companies. Alawad Fund was launched. Afterwards, he expressed his hope that the slogan ‘Blockchain as the future of finance and Dubai as the future of blockchain companies’ would be widely known around the world by actively investing and supporting promising projects together with various oil conglomerates. Media Contact Company: MetaBitcoin Contact: Media Team Email: info@meta-btc.org Website: https://meta-btc.org/ SOURCE: MetaBitcoin The article is provided by a third-party content provider. SEAPRWire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Hong Kong: AsiaExcite, EastMud; AsiaEase; Singapore: SEAChronicle, VOASG; NetDace; Thailand: SEAsiabiz, AccessTH; Indonesia: SEATribune, DailyBerita; Philippines: SEATickers, PHNotes; Malaysia: SEANewswire, KULPR; Vietnam: SEANewsDesk, PostVN)
More
Murata and Mitsubishi Agree on a Cooperative Framework for Working Toward a Carbon-Neutral Society JCN Newswire

Murata and Mitsubishi Agree on a Cooperative Framework for Working Toward a Carbon-Neutral Society

June 24, 2022
TOKYO, Jun 24, 2022 - (JCN Newswire via SEAPRWire.com) - Mitsubishi Corporation and Murata Manufacturing Co., Ltd. have agreed on a cooperative framework for working toward a carbon-neutral society.Virtual PPA Overview This framework is being developed with the aim of achieving carbon neutrality at the global level, while introducing renewable energy at the company level to achieve a sustainable society. On the road to decarbonization, it is important to combine initiatives achievable in the short term (such as constructing more renewable energy generation facilities) with more long-term goals (such as developing technologies that utilize hydrogen), to maintain a continuous, stable supply of renewable energy from diverse energy sources. To this end, companies with strengths in different areas must work together to pave the way for the next generation of energy: promoting efforts toward practical adoption, starting with real-world testing. Cooperation details (four areas)- Procurement of electricity from renewable energy sources by Murata- Production and use of hydrogen at Murata's plants in Japan- Working together with local communities via the creation of autonomous, decentralized communities- Regulating power through the use of storage batteries Through this cooperation, Murata Manufacturing Group has agreed to procure 70,000 kW of power derived from renewable energy sources from Mitsubishi by 2025, another step toward our goal of using 100% renewable energy by 2050, and the specific details are currently being finalized. We will continue our discussions with Mitsubishi, with the aim of expanding the amount procured to 300 million kWh in the future. This cooperation is being concluded on the premise that the power is procured under the virtual power purchase agreement (virtual PPA) scheme that has just started in Japan. We will also continue to update our medium- and long-term initiatives based on the shared areas of concern in this cooperation. Norio Nakajima, president of Murata Manufacturing, had this to say about the cooperative framework:"Every company in the Murata Manufacturing Group is doing its part to promote the introduction of renewable energy, but many of the things that will be critical in the future are difficult to do alone, from a technical standpoint. Mitsubishi has a track record of bringing renewable energy to a large number of locations both in Japan and worldwide as part of its drive to tackle social issues, and it owns many businesses aimed at putting different types of energy into practical use. By combining the know-how of Murata and Mitsubishi, we hope to contribute to the realization of a sustainable society, and development of society in general." Mitsubishi President Katsuya Nakanishi commented:"I am very pleased that we have been able to reach an agreement on a comprehensive framework of cooperation with Murata, which is already working on low-carbon/decarbonization initiatives to meet the RE100 targets. In May 2022, we announced our "Midterm Corporate Strategy 2024 - Creating MC Shared Value," which promotes energy transformation (EX), digital transformation (DX), and a growth strategy of future creation (regional development/new industry generation) through the unified promotion of EX and DX. Through this comprehensive cooperation, Mitsubishi and Murata will work jointly to create value at scale and contribute to low-carbon/decarbonization and regional development in Japan." Cooperation detailsProcurement of electricity from renewable energy sourcesAs part of our quest to convert all electricity consumed in the Murata Manufacturing Group's business activities into renewable energy to meet the goals of the RE100 global environmental initiative, we will procure renewable energy from a new solar power generation facility operated by Mitsubishi.Both companies have agreed that the scale of the solar power generation facility and amount procured will be approximately 70,000 kW by 2025, and are currently in the process of finalizing the terms of the procurement agreement. Together, we also aim to expand the amount of renewable energy procured to around 300 million kWh in the future.In this agreement, the power derived from renewable energy sources supplied by Mitsubishi to Murata will be done through a method called virtual PPA, in which non-FIT non-fossil fuel energy certificates are traded directly between renewable energy providers and consumers. Furthermore, the power generation facilities involved in this cooperation will all be newly built, creating renewable energy provision with additionality that will contribute to domestic carbon neutrality targets. Trial production and use of hydrogenWe will begin trialing the production and use of hydrogen at Murata's plants in Japan, using an electrolyzer. By utilizing carbon-free electricity in the electrolysis process and using the resulting hydrogen, we hope to reduce the greenhouse gas emissions that come from manufacturing.In the future, we also hope to supply hydrogen to the local communities where Murata's domestic plants are located, with the aim of promoting decarbonization in the region. Regional development with local communitiesWe aim to realize Murata's pledge to "solve social issues in all our corporate activities and contribute to society through our business activities" and Mitsubishi's "regional development through the unified promotion of EX and DX."In regions where Murata's domestic plants are located, we contribute to solving regional social and industrial issues together with local authorities along the theme of creating attractive, autonomous, and decentralized towns. Regulating power through the use of storage batteriesIn anticipation of entering the power supply and demand regulation market through our cooperation with Mitsubishi, which has a proven track record in this sector, we will jointly trial regulating the power supply through the use of storage batteries installed at Murata plants.By combining the proprietary power control technology used at Murata's production plants with Mitsubishi's knowledge of the electric power industry, we will strive to help resolve grid instability that may occur as the use of renewable energy increases.Inquiry RecipientMitsubishi CorporationTelephone:+81-3-3210-2171 Facsimile:+81-3-5252-7705 Copyright 2022 JCN Newswire. All rights reserved. (via SEAPRWire)
More
Grand Ming Group Holdings Limited Announces Annual Results for the Year Ended 31 March 2022 ACN Newswire

Grand Ming Group Holdings Limited Announces Annual Results for the Year Ended 31 March 2022

June 24, 2022
HONG KONG, Jun 24, 2022 - (ACN Newswire via SEAPRWire.com) - Grand Ming Group Holdings Limited (the "Company" and together with its subsidiaries, the "Group", stock code: 1271.HK) today announces its annual results for the year ended 31 March 2022 ("FY 2021/22").Highlights-- Revenue amounted to HK$817.9 million, a decrease of 45.2% from the previous financial year.-- Net profit for the year was HK$17.5 million, representing a decrease of 88.2%.-- Proposed payment of final dividend of 4.0 HK cents per share.-- Stay positive toward lucrative business of owning and operating data centres via expanding portfolio of developing two new centres in near future.-- Seize opportunity to increase land reserve for property development in Hong Kong.-- Execute the plan for property development in Nanning, Guangxi Province, China targeting for luxurious senior residential market.The Group's consolidated revenue decreased approximately 45.2% from approximately HK$1,492.4 million for the year ended 31 March 2021 ("FY 2020/21") to approximately HK$817.9 million for FY 2021/22. The decrease was primarily caused by lower revenue recognised from the building construction project at Kai Tak which was at the completion stage during FY 2021/22.The Group's net profit for FY 2021/22 amounted to approximately HK$17.5 million, representing a decrease of 88.2% when compared to that of approximately HK$149 million for FY 2020/21. Earnings per share was 1.2 HK cents (2021: 10.5 HK cents). The deterioration in results for FY 2021/22 was attributed by (i) reduction of revenue and profit recognised from the Kai Tak construction project which was at the completion stage; (ii) lower profit attained from the sales of typical units of Cristallo project; and (iii) loss incurred in certain variation orders of a completed construction project. Disregarding the changes in fair value of investment properties, the Group recorded an underlying loss of approximately HK$75.2 million (FY 2020/21: underlying profit of HK$148 million). The Group believes a long-term high dividend policy is the best reward for our loyal shareholders. The Board now recommends to pay a final dividend for FY 2021/22 of 4.0 HK cents per share. Together with the interim dividend of 4.0 HK cents per share and special interim dividend of 20.0 HK cents per share already paid, the total dividends for FY 2021/22 amounted to 28.0 HK cents per share. During FY 2021/22, revenue derived from the construction business decreased by approximately 65.1%, from approximately HK$1,133.7 million for FY 2020/21 to approximately HK$395.5 million for FY 2021/22. The decrease was primarily attributed to lower revenue recognised from the Kai Tak construction project which was at the completion stage during FY 2021/22.The data centre leasing business recorded healthy growth in the year under review, representing a testament to the resiliency of the portfolio and right strategy over the years. Revenue derived from its two high-tier data centre buildings, namely iTech Tower 1 and iTech Tower 2 increased approximately 18.4%, from approximately HK$164.7 million for FY 2020/21 to approximately HK$195.0 million for FY 2021/22, primarily driven by increased utilisation of data centre spaces in iTech Tower 2 by committed customers. The Group looks ahead from a position of strength to a focus on growth, and continues to execute the strategy of creating a stable and growing cash flow stream, the Group further diversifies its footprint for high-tier data centres. The two greenfield sites at No.3 On Kui Street and No.8 On Chuen Street in Fanling, the New Territories will be developed into two new high-tier data centres for leasing purposes, with an estimated gross floor area of approximately 185,000 square feet in aggregate. Currently the application for change of land use change of both sites by way of land exchange are in progress. The development at No.3 On Kui Street and No.8 On Chuen Street is scheduled for completion in mid-2025 and mid-2026 respectively.The Group's luxury residential project, CRISTALLO, at No. 279 Prince Edward Road West, Kowloon was well sold. During the year sales of 6 residential units were completed, and revenue of approximately HK$221.7 million was recognized accordingly."The Grand Marine" in Tsing Yi had achieved an encouraging sales performance, with over 92% of the units sold cumulatively. The certificate of compliance of the development was granted in March 2022. Accordingly, handover of the sold units to the buyers commenced from mid-April 2022, with HK$4.75 billion revenue recognised in the first half of our financial year 2022/23. For the property development in Mainland China, the Group acquired its first land parcel in July 2021 through government public auction. The land parcel is located at Guangxi-ASEAN Economic and Technological Development Zone, Wuming District, Nanning City, Guangxi Province. The site has an area of approximately 574,000 square feet, and is planned to be developed into a luxury residential project under the theme of leisure and healthy lifestyle targeting customers at the elderly and retirees and their families. The preliminary design comprises high-rise apartment units, villas, retail shops and a wellness centre. The estimated gross floor area of the proposed development is approximately 1,100,000 square feet. Site clearance works had been completed. Planning and design works are in progress.Mr. Chan Hung Ming, Chairman and Executive Director of Grand Ming Group Holdings concluded, "The achievement of our first property development project of the Grand Marine confirms our successful transition to a property developer which emboldens us to deliver satisfactory results in the coming year. We will continue to launch the sales for the remaining units of the Grand Marine and Cristallo so as to contribute further cash inflows to the Group.""Looking forward, year 2022 remains a year full of challenges conditioned by heightened uncertainty, including potential resurgence of another wave of covid-19 infections, local interest rate hike triggered by the U.S. Federal Reserve's move to hike rates and the global geopolitical tensions. On the other side, resilient demand from the local end-users, limited land supply and low mortgage rate environment continued to support the local residential mass market. We maintain a cautiously optimistic view on the residential property market. Facing with these challenges and uncertainties, we would continue to adopt our prudent approach in managing the Group's businesses and strategies, and searching meticulously for suitable new property development projects both in Hong Kong and Nanning City of Mainland China to build the long-term development roadmap of the Group. The acceleration of digital transformation in business operations and communication among individuals during the pandemic had led to a surge in demand of high-tier data centres and therefore we are committed to developing our two new data centres in Fanling and looking for new pipelines for growth."About Grand Ming Group Holdings Limited (Stock code: 1271.HK)The Group is principally engaged in the business of building construction, property leasing and property development. As a local wholesale co-location provider of high-tier data centres, the Group is one of the dedicated service providers in Hong Kong which owns and uses the entire building for leasing to customers for data centre use. Its clientele includes multinational data centre operator, telecommunications company and financial institutions. The Group operates two high-tier data centre buildings, namely iTech Tower 1 and iTech Tower 2. It also acquired two pieces of land in Fanling, the New Territories for developing into two high-tier data centres. Furthermore, the Group launches a residential development project namely "The Grand Marine" at Sai Shan Road, Tsing Yi, as well as a luxury residential project, Cristallo, at Prince Edward Road West, Kowloon. The Group owns a piece of land at No.1 Luen Fat Street, Fanling, New Territories and a site at No. 41, 43, 45 Pau Chung Street, To Kwa Wan, Kowloon, for developing each into a residential-cum-retail complex with an aggregate gross floor area of approximately 67,000 square feet. In Mainland China the Group owns a piece of land at Guangxi-ASEAN Economic and Technological Development Zone, Wuming District, Nanning City, Guangxi Province with a site area of approximately 574,000 square metres and the estimated gross floor area of the proposed residential development is approximately 1,100,000 square feet.Media Contacts:Angel YeungJovian Communications LtdEmail: news@joviancomm.com Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More
Pertamina’s largest share of 2021 profit from upstream sector ACN Newswire

Pertamina’s largest share of 2021 profit from upstream sector

June 23, 2022
JAKARTA, Jun 23, 2022 - (ACN Newswire via SEAPRWire.com) - The upstream sector accounted for the largest share of state-owned oil and gas firm PT Pertamina's (Persero's) net profit as Indonesian crude prices (ICP) soared in 2021.Pertamina Hulu Energi Offshore Southeast Sumatra (PHE OSES) well in Seribu Islands waters off North Jakarta's coast (ANTARA FOTO/M Risyal Hidayat/rwa)"The overall profit earned is a combination of the six sub-holdings and their subsidiaries, but the largest contribution to the net profit comes from the upstream sector due to the windfall from the increase in ICP prices," acting vice president of corporate communications at Pertamina, Heppy Wulansari, said in Jakarta on Tuesday.Reporting its 2021 fiscal year performance to the government, which is a shareholder in the company, Pertamina said it scored a net profit of Rp29.3 trillion.The majority of this profit was obtained from the upstream sector's revenue, which increased sharply. Meanwhile, the downstream sector experienced losses due to the increase in crude oil prices and as Pertamina's fuel prices remained below the market price.This was an advantage for Pertamina, which has an integrated business from upstream to downstream, which allows cross-subsidies. Thus, it could maintain the balance between profits and public service bonds.Wulansari said that Pertamina's financial performance was positive, with almost doubled profit in the 2021 fiscal year.This profit was consolidated profit from all Pertamina business lines from upstream, processing, and downstream.As for the downstream sector, especially fuel and LPG marketing and distribution, at this time, the status is still at a loss due to the high cost of fuel production as the largest component is crude oil."However, Pertamina really appreciates the government's full support through the payment of assignment fuel compensation and the addition of energy subsidies in the 2022 State Budget. This is very meaningful to maintain people's purchasing power and encourage economic recovery," Wulansari said.Contact: Fajriyah Usman, VP Corporate Communications, PT Pertamina (Persero)M: +62 858 8330 8686, Email: fajriyah.usman@pertamina.com, URL: https://www.pertamina.comWritten by: Azis Kurmala, Editor: Suharto (c) ANTARA 2022 Copyright 2022 ACN Newswire. All rights reserved. (via SEAPRWire)
More

MentorCall Launches a Mobile App for People to Find Mentors Online

June 15, 2022
New York, NY, June 15, 2022 – (SEAPRWire) – The Randstad, Netherlands / / 13 JUNE, 2022 / MentorCalls released a mobile app for connecting people with renowned professionals and leading industry minds to help people find the guidance they need to start or further their respective careers. MentorCalls is a startup app which allows users to connect with experts from different fields around the world and find the mentorship needed for professional development. The app helps aspiring entrepreneurs, athletes and artists secure a one-on-one interaction with mentors over a 1:1 video call through the platform. These mentors are prominent people in respective fields who provide answers to burning questions, give professional advice, and guide mentees on how to navigate rocky situations. Mentors interested in impacting knowledge on upcoming talents in a variety of fields can join the MentorCalls network and charge potential mentees per minute. Trainers who are less concerned about the money and are more about nurturing young ambitions have the option of donating their proceedings to charity. The mentors indicate when and how long they will be available so mentees can prepare for brief or elaborate sessions. The app currently hosts a good number of mentors from other parts of the world besides the Netherlands; such as Italy, the United States, Belgium, Australia, and Dubai. MentorCalls vision is to onboard world-class professionals on the top of their niche. MentorCalls believes learning from mentors can significantly reduce the amount of time and resources it takes to accomplish a dedicated goal. By walking mentees through their personal experience in a particular endeavor, Mentors help them avoid the unnecessary detours and unproductive efforts that prolong the road to success. NFTs Meet a Real Business The app brilliantly leverages the trend of NFTs in the crypto space. Buying the NFT gives you several online and real live benefits, including holders-only guest lectures from world most famous speakers and giveaways for call credits in the app. Besides, MentorCalls will roll out staking mechanics, making it possible to earn passive rewards in the form of an accompanying token. At the time of writing, the MentorCalls private token sale is already underway, and almost sold out. The MentorCalls app is available for download on Google Play and App Store. Background: Narrative Behind the Establishment of MentorCalls MentorCalls was co-founded by Danny Coppenrath and Maurice Weber; two successful entrepreneurs, Danny in the Rum business, and Maurice, owner of Crebos, in the software industry. They both undeniably attribute the success of their projects to mentors. Danny’s grandfather, Will Coppenrath, a rum aficionado who knew the ins-and-outs of the industry, fancied the idea of a luxury Rum bottled with a glass cap. In November 2020, he executed the concept, and launched the Baron Spiced Rum with a label that reads “Mountain with A Way Up”. Sadly, Will passed away due to the effects of the Coronavirus, just a few weeks before the marketing campaign for the rum was scheduled to kick off. However, Danny had spent some time under the wings of his grandfather, who showed him the ropes of the industry, and taught him everything he needed to know to efficiently run the business in Will’s absence. Danny, a few nephews and some other relatives stepped up to run the business and did a stellar job thanks to Will’s mentorship. Today, Baron Spice Rum can be found in over 170 liquor stores, 60 catering services and is sold in more than three different countries. In the same way, Maurice’s exploits in the software industry cannot be mentioned without a vote thanks to his mentor. Seeing the major influence mentors had in the success of both their careers, they were determined to help disadvantaged people globally find mentors that will ignite theirs. They understood that not everyone is lucky enough to have a mentor due to several hindering factors. In Danny’s words: “What if you are in a neighborhood where there are no mentors? Suppose you want to start a business, but you don’t know where to start? What if you want to grow, but don’t know who to turn to? Or what if you have a great idea, but have no one to share it with? Or if you can’t find the motivation to follow your dreams?” And so, the two Rotterdam best friends took it upon themselves to develop an app that connects a mentor and mentee over a video call. It was a very lofty ambition. Without digging into their personal savings for funding and Maurice’s expertise in software development, MentorCalls would be nothing but a dream. They started working on the app during the period of COVID-19 pandemic. The resources from Maurices software company and their joint investment facilitated the development of the MentorCalls project. After 14 months of fervently working on the app developments, the app is now live and available on Android and iOS devices. How MentorCall Changes Lives The major concept behind MentorCalls was providing mentorship programs for people in which a mentor would be otherwise scarce or inaccessible. To this end, MentorCalls is calling all mentors with solid knowledge in different industries and niches to share insight, knowledge and guide upcoming entrepreneurs. According to the MentorCall founders: “Many are already doing most things right. All they need is that extra motivation, or that one piece of missing advice that changes their lives. Nothing motivates a dreamer more than seeing someone who has gone through their struggles and succeeded at the end. Having a live encounter with a fulfilled person in a particular field can cast away doubt and reinforce people’s belief in the realization of their dreams through resilient efforts”. About MentorCalls MentorCalls is the first NFT-powered mobile app that makes mentors – from all corners of the world and across various fields or studies – accessible to people remotely through 1:1 video calls. MentorCall strives to make the world a better place by providing guidance for young talents and encouraging donations to charitable causes. Media Contact Company: MentorCalls Contact Person: Maurice Weber Email: info@mentorcalls.io Website: https://mentorcalls.io/ SOURCE: MentorCalls The article is provided by a third-party content provider. SEAPRWire ( www.seaprwire.com ) makes no warranties or representations in connection therewith. Any questions, please contact cs/at/SEAPRWire.com Sectors: Top Story, Daily News SEA PRWire: PR distribution in Southeast Asia (Indonesia, Thailand, Vietnam, Singapore, Malaysia, Philippines & Hong Kong )
More